Quốc gia: Ai-len
Ngôn ngữ: Tiếng Anh
Nguồn: HPRA (Health Products Regulatory Authority)
EZETIMIBE, SIMVASTATIN
B & S Healthcare
C10BA02
EZETIMIBE, SIMVASTATIN
10/40 Milligram
Tablets
Product subject to prescription which may be renewed (B)
HMG CoA reductase inhibitors in combination with other lipid modifying agents
Authorised
2013-03-01
PACKAGE LEAFLET: INFORMATION FOR THE USER INEGY ® 10MG/40MG TABLETS (EZETIMIBE AND SIMVASTATIN) READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. If you get any of the side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. The name of your medicine is Inegy 10mg/40mg Tablets, but will be referred to as Inegy throughout this leaflet. Please note that this leaflet also contains information about other strengths Inegy 10mg/20mg Tablets and Inegy 10mg/80mg Tablets. WHAT IS IN THIS LEAFLET: 1. What Inegy is and what it is used for 2. What you need to know before you take Inegy 3. How to take Inegy 4. Possible side effects 5. How to store Inegy 6. Contents of the pack and other information 1. WHAT INEGY IS AND WHAT IT IS USED FOR Inegy is a medicine used to lower levels of total cholesterol, “bad” cholesterol (LDL cholesterol), and fatty substances called triglycerides in the blood. In addition, Inegy raises levels of “good” cholesterol (HDL cholesterol). Inegy works to reduce your cholesterol in two ways. The active ingredient ezetimibe reduces the cholesterol absorbed in your digestive tract. The active ingredient simvastatin belonging to the class of “statin” inhibits the production of the cholesterol your body makes by itself. Cholesterol is Đọc toàn bộ tài liệu
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Inegy 10 mg / 40 mg Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 10mg ezetimibe and 40mg simvastatin. Also contains Lactose monohydrate. For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Tablet _Product imported from Spain:_ White to off-white capsule-shaped tablets with code “313” on one side. 4 CLINICAL PARTICULARS As per PA0035/095/003 5 PHARMACOLOGICAL PROPERTIES As per PA0035/095/003 6 PHARMACEUTICAL PARTICULARS 6.1 LIST OF EXCIPIENTS Butylated hydroxyanisole Citric acid monohydrate Croscarmellose sodium Hypromellose Lactose monohydrate Magnesium stearate Microcrystalline cellulose Propyl gallate 6.2 INCOMPATIBILITIES Not applicable. 6.3 SHELF LIFE The shelf life expiry date of this product shall be the date shown on the blister and outer carton of the product on the market in the country of origin. 6.4 SPECIAL PRECAUTIONS FOR STORAGE Do not store above 30°C. Store in the original pack in order to protect from light and moisture. HEALTH PRODUCTS REGULATORY AUTHORITY ________________________________________________________________________________________________________________________ _Date Printed 11/03/2015_ _CRN 2157920_ _page number: 1_ 6.5 NATURE AND CONTENTS OF CONTAINER Push-through blisters of opaque polychlorotrifluoroethylene /PVC sealed to vinyl coated aluminum in packs of 28 tablets. 6.6 SPECIAL PRECAUTIONS FOR DISPOSAL AND OTHER HANDLING No special requirements. 7 PARALLEL PRODUCT AUTHORISATION HOLDER B&S Healthcare Unit 4 Bradfield Road Ruislip Middlesex HA4 0NU United Kingdom 8 PARALLEL PRODUCT AUTHORISATION NUMBER PPA1328/203/001 9 DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION Date of first authorisation: 1st March 2013 10 DATE OF REVISION OF THE TEXT March 2015 HEALTH PRODUCTS REGU Đọc toàn bộ tài liệu